Duff K - Search Results

1

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.

Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K. Noble W, et al. Among authors: duff k. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6990-5. doi: 10.1073/pnas.0500466102. Epub 2005 May 2. Proc Natl Acad Sci U S A. 2005. PMID: 15867159 Free PMC article.

2

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA. Refolo LM, et al. Among authors: duff k. Neurobiol Dis. 2000 Aug;7(4):321-31. doi: 10.1006/nbdi.2000.0304. Neurobiol Dis. 2000. PMID: 10964604

3

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

Matsuoka Y, Picciano M, Malester B, LaFrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O'Banion MK, Tenner AJ, Lemere CA, Duff K. Matsuoka Y, et al. Among authors: duff k. Am J Pathol. 2001 Apr;158(4):1345-54. doi: 10.1016/S0002-9440(10)64085-0. Am J Pathol. 2001. PMID: 11290552 Free PMC article.

4

Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.

Matsuoka Y, Picciano M, La Francois J, Duff K. Matsuoka Y, et al. Among authors: duff k. Neuroscience. 2001;104(3):609-13. doi: 10.1016/s0306-4522(01)00115-4. Neuroscience. 2001. PMID: 11440793

5

Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.

Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston WJ, McGowan E, Farrer M, Hardy J, Duff K, Przedborski S, Di Monte DA. Matsuoka Y, et al. Among authors: duff k. Neurobiol Dis. 2001 Jun;8(3):535-9. doi: 10.1006/nbdi.2001.0392. Neurobiol Dis. 2001. PMID: 11442360

6

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE. Refolo LM, et al. Among authors: duff ke. Neurobiol Dis. 2001 Oct;8(5):890-9. doi: 10.1006/nbdi.2001.0422. Neurobiol Dis. 2001. PMID: 11592856

7

Statin therapy for Alzheimer's disease: will it work?

Petanceska SS, DeRosa S, Olm V, Diaz N, Sharma A, Thomas-Bryant T, Duff K, Pappolla M, Refolo LM. Petanceska SS, et al. Among authors: duff k. J Mol Neurosci. 2002 Aug-Oct;19(1-2):155-61. doi: 10.1007/s12031-002-0026-2. J Mol Neurosci. 2002. PMID: 12212773

8

Cholesterol in Alzheimer's disease and tauopathy.

Burns M, Duff K. Burns M, et al. Among authors: duff k. Ann N Y Acad Sci. 2002 Nov;977:367-75. doi: 10.1111/j.1749-6632.2002.tb04839.x. Ann N Y Acad Sci. 2002. PMID: 12480774 Review.

9

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

Matsuoka Y, Saito M, LaFrancois J, Saito M, Gaynor K, Olm V, Wang L, Casey E, Lu Y, Shiratori C, Lemere C, Duff K. Matsuoka Y, et al. Among authors: duff k. J Neurosci. 2003 Jan 1;23(1):29-33. doi: 10.1523/JNEUROSCI.23-01-00029.2003. J Neurosci. 2003. PMID: 12514198 Free PMC article.

10

Organotypic slice cultures from transgenic mice as disease model systems.

Duff K, Noble W, Gaynor K, Matsuoka Y. Duff K, et al. J Mol Neurosci. 2002 Dec;19(3):317-20. doi: 10.1385/JMN:19:3:317. J Mol Neurosci. 2002. PMID: 12540058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters